TYP 0.00% 1.9¢ tryptamine therapeutics limited

Ann: Quarterly Activities Report and Appendix 4C, page-28

  1. 5,813 Posts.
    lightbulb Created with Sketch. 1783
    Markets are in for a bumpy 6 to 12 months IMO. However, the healthcare space is one that should do ok. I suspect we get 12 months of costs rising a bit and interest rates might tick up, but then things will level off. EX1 has plenty cash. I am a firm advocate of the story pushed by Cathie Wood that we will see a convergence of computer science, AI and medicine/genomics etc over the next 5 to 10 years that will transform healthcare just as the internet has transformed our lives since the 90's

    I fully expect good returns will be a while in coming here, but just because there is not much they can report I am extremely confident the team are working very hard in the background. This is a gem I'm not letting go of and ranks as one of my highest $ holdings
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
1.9¢
Change
0.000(0.00%)
Mkt cap ! $20.69M
Open High Low Value Volume
1.9¢ 1.9¢ 1.8¢ $32.08K 1.692M

Buyers (Bids)

No. Vol. Price($)
2 527571 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 249986 1
View Market Depth
Last trade - 14.23pm 08/07/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.